Sep. 30 at 2:53 PM
$QCLS $PMCB I think JJ is closer to right than wrong on this one:
PharmaCyte had approximately
$15.5 million in cash and also holds over
$30 million of securities as reflected in the Company’s most recent 10K. With the addition of the
$7 million in proceeds from this financing, the Company’s balance sheet has been further strengthened, providing significant financial flexibility to support its ongoing business initiatives and strategic growth opportunities.